News

Novel drug shows promise for helping people with a type of heart failure that once left them facing dire prognoses and declining quality of life.

Nanowired cardiac organoids could one day repair hearts instead of just preventing further damage.

With SCTR pilot funding, a bioengineer and vascular surgeon collaborate on potentially heart-saving science.

If Clearview Surgical and Dr. Marc Katz have their way, AR could be the future of surgery in the not-too-distant future.

Doctors at MUSC Health are excited to participate in a trial demonstrating a less invasive way to implant a heart failure device.

MUSC researchers have developed a way to remove toxic chemotherapeutic drugs from the blood after cancer treatment to prevent them from reaching the heart.

A new way of doing CT scans means less radiation and better images - and MUSC researchers are helping to fine tune the technology.

MUSC researchers discover a potential biomarker that predicts severity of heart disease in African American lupus patients.

A new team at MUSC Health aims to help more people across the state survive cardiogenic shock – a rare but life-threatening condition.

A radiology artificial intelligence program proved so useful that the technology will now be used across the MUSC Health system.